Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Valcyte

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,676Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gpp Generic Valganciclovir Hydrochloride Receives Approval in US
    Gpp Generic Valganciclovir Hydrochloride Receives Approval in US

    11 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212876

    FDA
    11 Jun 2024
    Share Share
    Aurobindo's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.
    Aurobindo's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.

    17 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215124

    FDA
    17 Nov 2022
    Share Share
    Hetero's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.
    Hetero's Generic Valganciclovir Hydrochloride Receives Approval in the U.S.

    04 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211475

    FDA
    04 Oct 2022
    Share Share
    Valganciclovir leads to low blood counts in kidney transplant recipients
    Valganciclovir leads to low blood counts in kidney transplant recipients

    22 Feb 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=146017&sid=2

    PHARMABIZ
    22 Feb 2022
    Share Share
    Airis Pharma's Generic Valganciclovir Hydrochloride Receives Approval in U.S.
    Airis Pharma's Generic Valganciclovir Hydrochloride Receives Approval in U.S.

    17 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210169

    FDA
    17 Feb 2022
    Share Share
    Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
    Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older

    02 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211202005653/en

    BUSINESSWIRE
    02 Dec 2021
    Share Share